Cargando…

Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab

In this case report, we present the clinical course of a woman with locally advanced mucosal melanoma of the oral cavity. She was initially treated with surgery with adjuvant local radiation of 50 Gy in 20 fractions. She quickly relapsed with an aggressive regional recurrence of the disease on the n...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsui, James M, Mihalcioiu, Catalin, Cury, Fabio L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922506/
https://www.ncbi.nlm.nih.gov/pubmed/29719740
http://dx.doi.org/10.7759/cureus.2238
_version_ 1783318207894913024
author Tsui, James M
Mihalcioiu, Catalin
Cury, Fabio L
author_facet Tsui, James M
Mihalcioiu, Catalin
Cury, Fabio L
author_sort Tsui, James M
collection PubMed
description In this case report, we present the clinical course of a woman with locally advanced mucosal melanoma of the oral cavity. She was initially treated with surgery with adjuvant local radiation of 50 Gy in 20 fractions. She quickly relapsed with an aggressive regional recurrence of the disease on the neck and with numerous pulmonary metastases. Immunotherapy with pembrolizumab was started, with initial good response and reduction in the size of the lesion in the neck. The regression, however, was short-lived, as the mass quickly grew at a remarkable rate and the lung lesions progressed significantly. Palliative local radiation of 24 Gy in three fractions delivered at days zero, seven, and 21 to the neck mass was eventually given with the goal to alleviate symptoms. An immediate tumor regression was observed after the first fraction of radiotherapy. Remarkably, the lung lesions had also started regressing following radiation. We believe this to be a case of abscopal effect witnessed during the delivery of radiotherapy. A review of the recent literature is also presented here.
format Online
Article
Text
id pubmed-5922506
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-59225062018-05-01 Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab Tsui, James M Mihalcioiu, Catalin Cury, Fabio L Cureus Radiation Oncology In this case report, we present the clinical course of a woman with locally advanced mucosal melanoma of the oral cavity. She was initially treated with surgery with adjuvant local radiation of 50 Gy in 20 fractions. She quickly relapsed with an aggressive regional recurrence of the disease on the neck and with numerous pulmonary metastases. Immunotherapy with pembrolizumab was started, with initial good response and reduction in the size of the lesion in the neck. The regression, however, was short-lived, as the mass quickly grew at a remarkable rate and the lung lesions progressed significantly. Palliative local radiation of 24 Gy in three fractions delivered at days zero, seven, and 21 to the neck mass was eventually given with the goal to alleviate symptoms. An immediate tumor regression was observed after the first fraction of radiotherapy. Remarkably, the lung lesions had also started regressing following radiation. We believe this to be a case of abscopal effect witnessed during the delivery of radiotherapy. A review of the recent literature is also presented here. Cureus 2018-02-27 /pmc/articles/PMC5922506/ /pubmed/29719740 http://dx.doi.org/10.7759/cureus.2238 Text en Copyright © 2018, Tsui et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Radiation Oncology
Tsui, James M
Mihalcioiu, Catalin
Cury, Fabio L
Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab
title Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab
title_full Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab
title_fullStr Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab
title_full_unstemmed Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab
title_short Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab
title_sort abscopal effect in a stage iv melanoma patient who progressed on pembrolizumab
topic Radiation Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922506/
https://www.ncbi.nlm.nih.gov/pubmed/29719740
http://dx.doi.org/10.7759/cureus.2238
work_keys_str_mv AT tsuijamesm abscopaleffectinastageivmelanomapatientwhoprogressedonpembrolizumab
AT mihalcioiucatalin abscopaleffectinastageivmelanomapatientwhoprogressedonpembrolizumab
AT curyfabiol abscopaleffectinastageivmelanomapatientwhoprogressedonpembrolizumab